INS and type 2 diabetes mellitus: Indeed, thiazolidinediones (TZDs), which are synthetic agonists of PPARγ, have been shown to enhance insulin sensitivity, TZDs were used to treat T2D until recently, after which they were taken off the market due to various complications, including heart failure.